DNAJC5 and malaria: This stage is the target of the RTS,S/AS01 vaccine, currently the most advanced malaria vaccine candidate, which acts through the induction of high levels of both anti-circumsporozoite (CSP) antibodies and CSP-specific CD4+ T cells, with a greater role being attributed to the antibody (4).